| Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ... The Lancet 397 (10269), 99-111, 2021 | 5531 | 2021 |
| Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four … M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ... The Lancet 397 (10277), 881-891, 2021 | 1384 | 2021 |
| The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings RW Paterson, RL Brown, L Benjamin, R Nortley, S Wiethoff, T Bharucha, ... Brain 143 (10), 3104-3120, 2020 | 1261 | 2020 |
| Clinical features and management of human monkeypox: a retrospective observational study in the UK H Adler, S Gould, P Hine, LB Snell, W Wong, CF Houlihan, JC Osborne, ... The Lancet Infectious Diseases 22 (8), 1153-1162, 2022 | 1106 | 2022 |
| Preexisting and de novo humoral immunity to SARS-CoV-2 in humans KW Ng, N Faulkner, GH Cornish, A Rosa, R Harvey, S Hussain, R Ulferts, ... Science 370 (6522), 1339-1343, 2020 | 945 | 2020 |
| Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B. 1.1. 7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study D Frampton, T Rampling, A Cross, H Bailey, J Heaney, M Byott, R Scott, ... The Lancet infectious diseases 21 (9), 1246-1256, 2021 | 477 | 2021 |
| Caring for critically ill patients with Ebola virus disease. Perspectives from West Africa RA Fowler, T Fletcher, WA Fischer, F Lamontagne, S Jacob, D Brett-Major, ... American journal of respiratory and critical care medicine 190 (7), 733-737, 2014 | 289 | 2014 |
| Nosocomial transmission of coronavirus disease 2019: a retrospective study of 66 hospital-acquired cases in a London teaching hospital HM Rickman, T Rampling, K Shaw, G Martinez-Garcia, L Hail, P Coen, ... Clinical infectious diseases 72 (4), 690-693, 2021 | 260 | 2021 |
| The effect of spike mutations on SARS-CoV-2 neutralization C Rees-Spear, L Muir, SA Griffith, J Heaney, Y Aldon, JL Snitselaar, ... Cell reports 34 (12), 2021 | 251 | 2021 |
| Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers CF Houlihan, N Vora, T Byrne, D Lewer, G Kelly, J Heaney, S Gandhi, ... The Lancet 396 (10246), e6-e7, 2020 | 249 | 2020 |
| Ebola virus disease NJ Beeching, M Fenech, CF Houlihan Bmj 349, 2014 | 243 | 2014 |
| Human papillomavirus infection and increased risk of HIV acquisition. A systematic review and meta-analysis CF Houlihan, NL Larke, D Watson-Jones, KK Smith-McCune, S Shiboski, ... Aids 26 (17), 2211-2222, 2012 | 234 | 2012 |
| Clinical presentation, biochemical, and haematological parameters and their association with outcome in patients with Ebola virus disease: an observational cohort study L Hunt, A Gupta-Wright, V Simms, F Tamba, V Knott, K Tamba, ... The Lancet infectious diseases 15 (11), 1292-1299, 2015 | 223 | 2015 |
| Family cluster of three cases of monkeypox imported from Nigeria to the United Kingdom, May 2021 G Hobson, J Adamson, H Adler, R Firth, S Gould, C Houlihan, C Johnson, ... Eurosurveillance 26 (32), 2100745, 2021 | 203 | 2021 |
| Cohort profile: Hlabisa HIV treatment and care programme CF Houlihan, RM Bland, PC Mutevedzi, RJ Lessells, J Ndirangu, ... International journal of epidemiology 40 (2), 318-326, 2011 | 191 | 2011 |
| Estimating the effectiveness of routine asymptomatic PCR testing at different frequencies for the detection of SARS-CoV-2 infections J Hellewell, TW Russell, R Beale, G Kelly, C Houlihan, E Nastouli, ... BMC medicine 19, 1-10, 2021 | 144 | 2021 |
| NHS England High Consequence Infectious Diseases (Airborne) Network. Clinical features and management of human monkeypox: a retrospective observational study in the UK H Adler, S Gould, P Hine, LB Snell, W Wong, CF Houlihan, JC Osborne, ... Lancet Infect Dis 22 (8), 1153-1162, 2022 | 143 | 2022 |
| Asymptomatic infection and unrecognised Ebola virus disease in Ebola-affected households in Sierra Leone: a cross-sectional study using a new non-invasive assay for antibodies … JR Glynn, H Bower, S Johnson, CF Houlihan, C Montesano, JT Scott, ... The Lancet infectious diseases 17 (6), 645-653, 2017 | 128 | 2017 |
| New filovirus disease classification and nomenclature JH Kuhn, T Adachi, NKJ Adhikari, JR Arribas, IE Bah, DG Bausch, ... Nature Reviews Microbiology 17 (5), 261-263, 2019 | 120 | 2019 |
| Genomic investigations of unexplained acute hepatitis in children S Morfopoulou, S Buddle, OE Torres Montaguth, L Atkinson, ... Nature 617 (7961), 564-573, 2023 | 106 | 2023 |
